These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3226360)

  • 41. Basal ganglia dopamine receptor autoradiography and age-related movement disorders.
    Marshall JF; Joyce JN
    Ann N Y Acad Sci; 1988; 515():215-25. PubMed ID: 3364885
    [No Abstract]   [Full Text] [Related]  

  • 42. The clinical physiology of side effects in long-term L-DOPA therapy.
    Barbeau A
    Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234
    [No Abstract]   [Full Text] [Related]  

  • 43. Serotonin modulation of the basal ganglia circuitry: therapeutic implication for Parkinson's disease and other motor disorders.
    Di Matteo V; Pierucci M; Esposito E; Crescimanno G; Benigno A; Di Giovanni G
    Prog Brain Res; 2008; 172():423-63. PubMed ID: 18772045
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vivo release of [3H]gamma-aminobutyric acid in the rat neostriatum--I. Characterization and topographical heterogeneity of the effects of dopaminergic and cholinergic agents.
    Girault JA; Spampinato U; Savaki HE; Glowinski J; Besson MJ
    Neuroscience; 1986 Dec; 19(4):1101-8. PubMed ID: 3493448
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Halothane and isoflurane differentially affect the regulation of dopamine and gamma-aminobutyric acid release mediated by presynaptic acetylcholine receptors in the rat striatum.
    Salord F; Keita H; Lecharny JB; Henzel D; Desmonts JM; Mantz J
    Anesthesiology; 1997 Mar; 86(3):632-41. PubMed ID: 9066330
    [TBL] [Abstract][Full Text] [Related]  

  • 46. N-methyl-D-aspartate-evoked release of [3H]acetylcholine in striatal compartments of the rat: regulatory roles of dopamine and GABA.
    Blanchet F; Kemel ML; Gauchy C; Desban M; Perez S; Glowinski J
    Neuroscience; 1997 Nov; 81(1):113-27. PubMed ID: 9300405
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The basal ganglia and the initiation of movement.
    Graybiel AM
    Rev Neurol (Paris); 1990; 146(10):570-4. PubMed ID: 2263819
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Functional aspects of serotonin transmission in the basal ganglia: a review and an in vivo approach using the push-pull cannula technique.
    Soubrié P; Reisine TD; Glowinski J
    Neuroscience; 1984 Nov; 13(3):605-25. PubMed ID: 6084828
    [No Abstract]   [Full Text] [Related]  

  • 49. The neurophysiologic basis of abnormal movements in basal ganglia disorders.
    DeLong MR
    Neurobehav Toxicol Teratol; 1983; 5(6):611-6. PubMed ID: 6422317
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Novel nondopaminergic targets for motor features of Parkinson's disease: review of recent trials.
    Kalia LV; Brotchie JM; Fox SH
    Mov Disord; 2013 Feb; 28(2):131-44. PubMed ID: 23225267
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Experimental basis of the therapy of Parkinson's disease and the cholinergic-dopaminergic equilibrium in basal brain nuclei.
    Wolfarth S
    Pol J Pharmacol Pharm; 1976; 28(5):469-93. PubMed ID: 796834
    [No Abstract]   [Full Text] [Related]  

  • 52. [Neuropharmacological regulation of pituitary hormones. Role of acetylcholine, gamma-aminobutyric acid, histamine and endorphins (author's transl)].
    Martin-du Pan R; Gomez F
    Ann Endocrinol (Paris); 1981; 42(2):79-112. PubMed ID: 7027896
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Neurotransmitters in the cerebral cortex.
    Jones EG
    J Neurosurg; 1986 Aug; 65(2):135-53. PubMed ID: 2873211
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Altered spontaneous discharge rate and pattern of basal ganglia output neurons in the circling (ci2) rat mutant.
    Fedrowitz M; Lindemann S; Löscher W; Gernert M
    Neuroscience; 2003; 118(3):867-78. PubMed ID: 12710993
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Gamma-aminobutyric acid: selective inhibition of electrically induced head-turning following intracaudate administration.
    Malick JB; Goldstein JM
    Arch Int Pharmacodyn Ther; 1976 Apr; 220(2):269-74. PubMed ID: 986127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neuropsychiatry of the basal ganglia.
    Ring HA; Serra-Mestres J
    J Neurol Neurosurg Psychiatry; 2002 Jan; 72(1):12-21. PubMed ID: 11784818
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Efficacies of agents related to GABA, dopamine, and acetylcholine in the treatment of tardive dyskinesia [proceedings].
    Chien C; Jung K; Ross-Townsend A
    Psychopharmacol Bull; 1978 Apr; 14(2):20-2. PubMed ID: 26102
    [No Abstract]   [Full Text] [Related]  

  • 58. Evidence for a role of neurotransmitters in the mechanism of topical convulsant models.
    Craig CR
    Fed Proc; 1984 Jul; 43(10):2525-8. PubMed ID: 6145629
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dopaminergic infllence in the basal ganglia: evidence for striatonigral feedback regulation.
    Bunney BS; Aghajanian GK
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():249-67. PubMed ID: 826996
    [No Abstract]   [Full Text] [Related]  

  • 60. Release of acetylcholine, gamma-aminobutyrate, dopamine and glutamate, and activity of some related enzymes, in rat gustatory neocortex.
    López-García JC; Bermúdez-Rattoni F; Tapia R
    Brain Res; 1990 Jul; 523(1):100-4. PubMed ID: 2207682
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.